Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria.
Level 5 - mechanism / opinion, no new human data
In vitro and in vivo laboratory bench research on cellular mechanisms
PubMed 11753563 · doi:10.1038/sj.cdd.4400946
What was done
Researchers investigated whether mature human erythrocytes, which lack nuclei and mitochondria, can undergo regulated programmed cell death. They evaluated the effects of calcium (Ca2+) influx and cysteine protease inhibitors on erythrocyte morphology, survival, and macrophage engulfment both in vitro and in vivo. They also assayed caspase-3 activation, cytochrome c presence, and nuclear apoptosis effectors using cell-free systems.
What was found
The abstract reports no quantitative values or statistical metrics. Qualitatively, Ca2+ influx triggered rapid erythrocyte self-destruction characterized by cell shrinkage, membrane microvesiculation, phosphatidylserine externalization, cell disintegration, and macrophage engulfment. Cysteine protease inhibitors prevented this death in vitro and in vivo. The process occurred without classical caspase activation: caspase-3 proforms were not cleaved, cytochrome c was absent, and cell-free assays detected no activated effectors of nuclear apoptosis.
Why it matters
The study provides proof-of-principle that regulated programmed cell death can function in human cells without mitochondria, nuclei, or active caspase cascades, establishing that red blood cell lifespan may be actively regulated by environmental signals.
Limits
The abstract reports no numerical data, sample sizes, specific drug names or dosages, or details of the in vivo model. As a purely preclinical laboratory mechanism study, direct clinical and therapeutic relevance in humans is not established.
Cited by
- supports Mature human red blood cells do not contain mitochondria.